PhD Defense: Advancing Therapeutic Drug Monitoring of oral targeted anticancer drugs; analytical and clinical studies ...
Due to their potential to accumulate in tumors, these nanoparticles have emerged as promising drug carriers for cancer ...
7d
Interesting Engineering on MSNGold nanoparticles take cancer treatment to the next level with imaging techThis could help make treatments safer and more precise, leading to better outcomes for cancer patients. Scientists in Japan ...
The global therapeutic drug monitoring market is poised for significant expansion, with projections indicating a rise from USD 1,203.9 million in 2024 to an impressive USD 2,527.9 million by 2034.
Background Voriconazole is approved for treatment of invasive aspergillosis and other invasive fungal infections, but the role for therapeutic drug monitoring (TDM) is not clear. Methods We ...
1d
Clinical Trials Arena on MSNEvinova and QLHC agree to incorporate RPM solution in breast cancer therapy trialHealthcare technology company Evinova has entered an agreement with Quantum Leap Healthcare Collaborative (QLHC) to ...
Gold nanoparticles (AuNPs) have emerged as promising drug carriers for cancer therapy and targeted drug delivery but tracking ...
The following is a summary of "Nanobodies targeting the tumor microenvironment and their formulation as nanomedicines," ...
Evinova makes it possible for us to monitor people using the drug every day, from the comfort of their home. Using Evinova’s RPM solution in the study will help us, as providers, to identify and ...
PR+ breast cancer responds well to hormone therapy, underscoring the need for molecular insight and targeted treatment ...
Metastatic melanoma is the most aggressive form of skin cancer. In an effort to achieve targeted therapy for metastatic melanoma, researchers recently developed a new radioactive drug that emits alpha ...
Researchers from SRM Institute of Science and Technology, led by Dr. KN Aruljothi, have published a study in ExRNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results